Duong D. Pham

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Type 2 Biomarkers as Mediators of Clinical Remission With Biologics in Severe Asthma.

Type 2 Biomarkers as Mediators of Clinical Remission With Biologics in Severe Asthma.

Journal: Allergy

Published: October 28, 2025

Reply to "Optimizing FeNO and blood eosinophil stratification in eosinophilic asthma study: Adjusting for smoking history and blood sampling time".

Reply to "Optimizing FeNO and blood eosinophil stratification in eosinophilic asthma study: Adjusting for smoking history and blood sampling time".

Journal: The journal of allergy and clinical immunology. In practice

Published: August 20, 2025

Epithelial-derived cytokines in the pathogenesis of severe asthma.

Epithelial-derived cytokines in the pathogenesis of severe asthma.

Journal: Frontiers in allergy

Published: August 07, 2025

Concurrent Blood Eosinophils and FeNO as Biological Therapy Indicators in Severe Asthma: Findings From the Precision Medicine Intervention in Severe Asthma Study.

Concurrent Blood Eosinophils and FeNO as Biological Therapy Indicators in Severe Asthma: Findings From the Precision Medicine Intervention in Severe Asthma Study.

Journal: The journal of allergy and clinical immunology. In practice

Published: February 04, 2025

Predictors of asthma exacerbation between high and low blood eosinophil counts.

Predictors of asthma exacerbation between high and low blood eosinophil counts.

Journal: ERJ open research

Published: November 20, 2024

Biomarkers of type 2 inflammation as predictors of response to biologics for severe eosinophilic asthma.

Biomarkers of type 2 inflammation as predictors of response to biologics for severe eosinophilic asthma.

Journal: ERJ open research

Published: September 25, 2024

Longitudinal multi-trajectory phenotypes of severe eosinophilic asthma on type 2 biologics treatment.

Longitudinal multi-trajectory phenotypes of severe eosinophilic asthma on type 2 biologics treatment.

Journal: The World Allergy Organization journal

Published: June 05, 2024

Transcriptomic Expression of T2-Inflammation Genes in Peripheral Blood Mononuclear Cells and Longitudinal Clinical Outcomes in Asthma: Insights from the COREA Study.

Transcriptomic Expression of T2-Inflammation Genes in Peripheral Blood Mononuclear Cells and Longitudinal Clinical Outcomes in Asthma: Insights from the COREA Study.

Journal: Lung

Published: March 29, 2024

Predictors of Early and Late Lung Function Improvement in Severe Eosinophilic Asthma on Type2-Biologics in the PRISM Study.

Predictors of Early and Late Lung Function Improvement in Severe Eosinophilic Asthma on Type2-Biologics in the PRISM Study.

Journal: Lung

Published: October 31, 2023

Prospective direct comparison of biologic treatments for severe eosinophilic asthma: Findings from the PRISM study.

Prospective direct comparison of biologic treatments for severe eosinophilic asthma: Findings from the PRISM study.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

Published: September 04, 2023

Longitudinal asthma phenotypes by multi-trajectory analysis.

Longitudinal asthma phenotypes by multi-trajectory analysis.

Journal: Allergy

Published: August 10, 2023

WITHDRAWN: Prospective direct comparison of biological treatments on severe eosinophilic asthma: Findings from the PRISM study.

WITHDRAWN: Prospective direct comparison of biological treatments on severe eosinophilic asthma: Findings from the PRISM study.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

Published: February 28, 2023

Showing 1-12 of 31

Last Updated: 09/26/2026